Images – pT3a clear-cell renal cell carcinoma in a renal allograft managed effectively with open partial nephrectomy
– Karczewski, M., Czapiewski, W., & Karczewski, J. Urologic de novo malignancies after kidney transplantation: A single center experience. Transplantation Proceedings, 2012. 44(5),1293-97.
– Elkentaoui, H., Robert, G., Pasticier, G., et al. Therapeutic management of de novo urological malignancy in renal transplant recipients: The experience of the French Department of Urology and Kidney Transplantation from Bordeaux. Urology, 2010, 75(1), 126-32.
– Melchior, S., Franzaring, L., Shardan, A., et al (2011). Urological de novo malignancy after kidney transplantation: A case for the urologist. The Journal of Urology. 2011, 185(2), 428-32.
– Penn, I., & Staezl, T. E. Malignant tumors arising de novo In immunosuppressed organ transplant recipients. Transplantation, 1972. 14(4), 407-17.
– Bieniasz, M., Chmura, A., Kwapisz, M.,et al. Renal tumor in allogeneic kidney transplant recipient. Transplantation Proceedings. 2016, 48(5), 1849-54.
– Faba, O. R., Breda, A., Gausa, L., et al. De novo urologic tumors in kidney transplant patients. Actas Urológicas Españolas (English Edition). 2015, 39(2), 122-27.
– Bustami, R. T., Ojo, A. O., Wolfe, R. et al. Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. American Journal of Transplantation. 2004. 4(1), 87-93.
– Guba, M., Graeb, C., Jauch, K., et al. Pro- and anti-cancer effects of immunosuppressive agents used In organ transplantation. Transplantation. 2004.77(12), 1777-82.
– Euvrard, S., Morelon, E., Rostaing, L., et al. Sirolimus and secondary skin-cancer prevention in kidney transplantation. New England Journal of Medicine. 2012. 367(4), 329-39.
– Boissier, R., Hevia, V., Bruins, H. M., et al. The risk of tumour recurrence in patients undergoing renal transplantation for end-stage renal disease after previous treatment for a urological cancer: A Systematic review. European Urology, 2018. 73(1), 94-108.
– Ribal, M., Rodriguez, F., Musquera, M., et al. Nephron-sparing surgery for renal tumor: A choice of treatment in an allograft kidney. Transplantation Proceedings. 2006. 38(5), 1359-62.
- Barama, A., St-Louis, G., Nicolet, V., et al. Renal cell carcinoma in kidney allografts: A case series from a single center. American Journal of Transplantation. 2005. 5(12), 3015-18.
You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:
- Post the Article on any Web site
- Translate or authorize a translation of the Article
- Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
- Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.
The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.
You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.
The CUA also requires you to warrant the following:
- That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
- That all individuals who have made a substantive contribution to the article are acknowledged;
- That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
- That the Article does not libel or violate the privacy rights of any third party.